Immediate Impact
57 standout
Citing Papers
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
2024 Standout
Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies
2024 Standout
Works of John Byron being referenced
Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| John Byron | 82 | 32 | 6 | 57 | 41 | 7 | 171 | |
| Panagiotis Taflampas | 235 | 5 | 1 | 82 | 24 | 9 | 290 | |
| Josephine Psaila | 75 | 4 | 21 | 54 | 6 | 124 | ||
| John H. Crandon | 19 | 8 | 16 | 7 | 7 | 7 | 131 | |
| Eugene L. Lozner | 74 | 4 | 10 | 5 | 20 | 10 | 186 | |
| C. Monka | 61 | 27 | 5 | 5 | 6 | 5 | 253 | |
| Hajrunisa Čubro | 25 | 149 | 3 | 13 | 20 | 10 | 282 | |
| P. Foray | 199 | 2 | 16 | 17 | 14 | 9 | 260 | |
| Karen Inglis | 97 | 3 | 4 | 14 | 25 | 8 | 271 | |
| Rishabh Sehgal | 137 | 5 | 20 | 12 | 11 | 11 | 271 | |
| Neda Ebrahimi | 63 | 23 | 6 | 3 | 35 | 7 | 256 |
All Works
Loading papers...